| Model Number |
MCENDO550 |
| Medical Device Problem Code |
Crack (1135)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/18/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
The user facility reported to terumo cardiovascular that during vein harvesting procedure, the scope had a smudge or crack in the scope.It is unknown whether there was a delay in the procedure.Due to the unknown information, it is being reported.Terumo continues to attempt to gain more information regarding this event from the user facility.
|
| |
|
Additional Manufacturer Narrative
|
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: h6 (identification of evaluation codes 10, 3331, 3224, 19).Type of investigation #1: 10 - testing of actual/suspected device.Type of investigation #2: 3331 - analysis of production records.Investigation findings: 3224 - optical problem identified.Investigation conclusions: 19 - cause traced to user.The sample was returned and visually inspected using a monocular and discovered that there was a crack on one of the internal lenses which resulted in a blurry visual field.These are the possible causes which may produce the failure: the product was either dropped or inadvertently struck by an object, the excessive force was exerted on the endoscope shaft; this could deflect the shaft and lead to the alteration of the internal lens system.The labeling for the device stresses the importance of how fragile the device is and instructs the user to handle the product with extreme care to prevent damage to the device.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
| |
|
Event or Problem Description
|
|
*there was 10 ml blood loss, *the product was changed out, *the surgery was completed successfully.
|
| |
|
Additional Manufacturer Narrative
|
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on may 17, 2022.Upon further investigation of the reported event, the following information is new and/or changed: d9 (device availability - added date returned to manufacturer).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information).H3 (device evaluation anticipated by manufacturer - a second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.) all available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
| |
|
Search Alerts/Recalls
|